Status:
COMPLETED
Evaluation of Influencing Variables in Awakening Concentration and Concentration at Body Movements of Propofol TCI (Targeted Controlled Infusion) Targeted at the Effector Site
Lead Sponsor:
University of Padova
Conditions:
Awareness, Anesthesia
Eligibility:
All Genders
18-90 years
Brief Summary
Age has been related to awakening propofol concentration at effector site of TCI, but not to the loss of consciousness concentration, neither to the concentration of body movements during surgery, tha...
Detailed Description
Target-Controlled-Infusion (TCI), estimating the effect-size concentration (Ce) of propofol and its elimination time with a computerized system, provides the anaesthesiologist useful information to gu...
Eligibility Criteria
Inclusion
- Patients undergoing general anesthesia with propofol and remifentanil delivered with TCI infusion pump
Exclusion
- neurological or psychiatric or cerebrovascular diseases
- renal insufficiency
- patients unable to understand the information contained in the informed consent form,
- patients with intraoperative hemodynamic instability or
- patients who was delivered curare agents during anaesthesia
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2019
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04129112
Start Date
July 1 2019
End Date
December 15 2019
Last Update
October 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ULSS 2 Marca Trevigiana
Treviso, Tv, Italy, 31100